Latest Asx Filings News

Qualitas Real Estate Income Fund (ASX: QRI) has launched a $151 million non-renounceable entitlement offer to existing unitholders, aiming to boost portfolio diversification and liquidity by investing in commercial real estate loans.

EDU Holdings Limited reports a robust 35% increase in total student enrolments for Term 1, 2025, despite a notable decline in new student intake and ongoing regulatory challenges.

Verity Resources has initiated a pit optimisation study on its Korong and Waihi gold deposits within the Monument Gold Project, aiming to capitalise on rising gold prices and unlock open-pit mining potential.

AGL Energy Limited has announced a fully franked ordinary dividend of AUD 0.23 per share for the six months ending December 2024, payable on March 27, 2025.

Dexus Industria REIT has reported a robust half-year performance for FY25, driven by high occupancy, significant leasing activity, and successful completion of a key development at ASCEND at Jandakot.

Arika Resources has identified extensive gold-bearing quartz reefs stretching over 4.5 kilometres at Banjo's Camp within the Yundamindra Gold Project, with rock chip samples grading up to 5.3 g/t Au. This discovery significantly expands the project's exploration potential ahead of planned drilling campaigns.

St Barbara Limited has announced its intention to separate its Atlantic Gold Operations in Nova Scotia, aiming to unlock value through a Canadian-led development while concentrating on its Papua New Guinea assets.

IMDEX Limited has announced a fully franked ordinary dividend of AUD 0.015 per share, signaling steady shareholder returns for the half-year ending December 2024.

Amotiv Limited has announced a fully franked interim dividend of AUD 0.185 per share for the half-year ending December 2024, signaling steady financial health and shareholder returns.

Commonwealth Bank of Australia announces a fully franked ordinary dividend of AUD 2.25 per share, payable March 28, 2025, reflecting solid financial results for the period ending December 31, 2024.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.

Sarama Resources has completed the second tranche of its A$2 million equity placement, issuing options to institutional investors after shareholder approval. The funds are earmarked for advancing exploration and supporting working capital.